Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nirogacestat in progressing desmoid tumors/aggressive fibromatosis
NCT03785964Phase 3Completed
- Sponsor
- SpringWorks Therapeutics
- Start
- Apr 2019
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of nirogacestat in desmoid tumor, sponsored by SpringWorks Therapeutics. Started Apr 2019; status: completed.
02
Drugs
nirogacestat
03
Conditions
desmoid tumor
Beyond the preview
Go deeper on NCT03785964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03785964.